StonvexLoading…
StonvexStonvexStonvexCore line items from SBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $3.70B | $3.72B | $3.73B | $3.82B |
Operating Income | $327.81M | $282.73M | $325.03M | $337.64M |
Net Income | $195.88M | $153.41M | $184.60M | $183.55M |
EPS (Diluted) | $1.89 | $1.43 | $1.69 | $1.66 |
Total Assets | $2.87B | $2.79B | $2.73B | $2.58B |
Total Liabilities | $2.08B | $2.16B | $2.22B | $2.28B |
Cash & Equivalents | $149.16M | $107.96M | $123.00M | $70.56M |
Free Cash Flow OCF − CapEx | $172.69M | $145.36M | $158.57M | $57.25M |
Shares Outstanding | 97.88M | 101.85M | 106.27M | 106.97M |